Send mail to Author

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _____       ___     _____      ______   _    _    __   __  
|  __ \\    / _ \\  |  __ \\   /_   _// | \  / ||  \ \\/ // 
| |  \ ||  | / \ || | |  \ ||   -| ||-  |  \/  ||   \ ` //  
| |__/ ||  | \_/ || | |__/ ||   _| ||_  | .  . ||    | ||   
|_____//    \___//  |_____//   /_____// |_|\/|_||    |_||   
 -----`     `---`    -----`    `-----`  `-`  `-`     `-`'
 


Back to frontdoor view

OPUS4 Logo